Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Palomo

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|March 22, 2012
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their originGorka Ruiz de Garibay, Sara Gutiérrez-Enríquez, Pilar Garre, et al.
Cancer Research Communications|February 1, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating TherapyIgnacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, et al.
Journal of Hepatology|May 22, 2017
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β inductionLester Suárez-Amarán, Carla Usai, Marianna Di Scala, et al.
Ebiomedicine|May 26, 2022
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5qVera Adema, Laura Palomo, Wencke Walter, et al.
Stem Cell Reports|May 23, 2017
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment OutcomesRafael Diaz de la Guardia, Belen Lopez-Millan, Jessie R Lavoie, et al.
Ejhaem|May 19, 2023
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotypeMar Mallo, Heinz Tuechler, Leonor Arenillas, et al.
Oncotarget|August 4, 2016
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic featuresLaura Palomo, Olga Garcia, Montse Arnan, et al.
Cancers|April 30, 2021
A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid NeoplasmsAlessandro Liquori, Iván Lesende, Laura Palomo, et al.
Frontiers in Oncology|July 16, 2024
Chronic myelomonocytic leukemia with ring sideroblasts/<i>SF3B1</i> mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/<i>SF3B1</i> mutation in terms of phenotype and prognosisBlanca Xicoy, Helena Pomares, Mireia Morgades, et al.
American Journal of Hematology|October 29, 2015
Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphasesLaura Palomo, Blanca Xicoy, Olga Garcia, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|March 22, 2012
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their originGorka Ruiz de Garibay, Sara Gutiérrez-Enríquez, Pilar Garre, et al.
Cancer Research Communications|February 1, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating TherapyIgnacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, et al.
Journal of Hepatology|May 22, 2017
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β inductionLester Suárez-Amarán, Carla Usai, Marianna Di Scala, et al.
Ebiomedicine|May 26, 2022
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5qVera Adema, Laura Palomo, Wencke Walter, et al.
Stem Cell Reports|May 23, 2017
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment OutcomesRafael Diaz de la Guardia, Belen Lopez-Millan, Jessie R Lavoie, et al.
Ejhaem|May 19, 2023
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotypeMar Mallo, Heinz Tuechler, Leonor Arenillas, et al.
Oncotarget|August 4, 2016
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic featuresLaura Palomo, Olga Garcia, Montse Arnan, et al.
Cancers|April 30, 2021
A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid NeoplasmsAlessandro Liquori, Iván Lesende, Laura Palomo, et al.
Frontiers in Oncology|July 16, 2024
Chronic myelomonocytic leukemia with ring sideroblasts/<i>SF3B1</i> mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/<i>SF3B1</i> mutation in terms of phenotype and prognosisBlanca Xicoy, Helena Pomares, Mireia Morgades, et al.
American Journal of Hematology|October 29, 2015
Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphasesLaura Palomo, Blanca Xicoy, Olga Garcia, et al.
Pageof 5